Indonesian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
15 hasil
Hydroxyalkyl starch for the treatment of hematological neoplasms
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a U.S. national phase application filed under 35 USC .sctn. 371 of International Application No. PCT/EP2014/066299, which was filed Jul. 29, 2014, and which claims the benefit of the filing date of EP Application No. 13003776.5, which was
Cryoprotected, frozen recombinant cancer cells
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The invention relates to compositions and methods for the cryopreservation of cellular vaccines. More specifically, the invention relates to the use of particular compositions comprising cryoprotective media that includes hydroxyethyl starch (HES) and glycerol or DMSO together
Highly fermentable resistant starch
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD
The present invention relates to a starch composition containing a high proportion of so-called "resistant starch" (RS). The composition of the resistant starch is further characterised by a specific chain length distribution of the RS-fraction and by a relatively low specific
Dry starch-iodine pharmaceutical formulations
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
The present invention is concerned with the use of starch containing amylose as a complexant with iodine for preparing dry powder pharmaceutical formulations useful in the preparation of capsules or tablets.
More particularly, the invention is concerned with the
Lipiodol-based anti-tumour emulsion for treating cancer
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates to a pharmaceutical composition comprising Lipiodol and a molecule with anti-tumour activity and secondarily a hydroxyethyl starch. The present invention also relates to the use of the compositions according to the invention for treating
Anti-tumoral therapy agent containing a contrast agent
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This application is a 371 of PCT/DE98/01514 Jun. 4, 1998.
BACKGROUND OF THE INVENTION
The invention relates to a new anti-tumoral therapy agent based on liposome-encapsulated cytostatic agents and/or the metabolites thereof. Fields of application of the invention are pharmaceutical industry and
Capillary membrane stabilization and reduction of inflammation during the course of chemotherapy or antiviral treatment through the use of biodegradable macromolecules and interleukin-2
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The present invention relates to a method for treating human subjects to prevent leakage of macromolecules from capillary endothelial junctions as a consequence of extremely severe and life threatening side effects due to cancer biological therapy for cancer, infectious diseases, septic shock, and
Polymeric carriers linked to nucleotide analogues via a phosphoramide bond
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
This invention relates to the synthesis of macromolecular prodrugs of nucleotide analogs and their uses as antiviral and anticancer agents.
BACKGROUND
Nucleoside analogs are a class of compounds that have been shown to exert antiviral and antitumor activity both in vitro and
Fatty acid delivery system comprising a hydrolyzable bond
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This application claims benefit of international application PCT/GB94/00713, filed Nov. 17, 1994, published as WO95/13801 May 26, 1995.
FIELD OF THE INVENTION
This invention relates to an agent for use in food, dietary, and the like preparations, and to preparations, formulations and dietary
Directly injectable formulations which provide enhanced cryoprotection of cell products
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The invention relates to compositions and methods for the cryopreservation of cellular vaccines. More specifically, the invention relates to the use of particular compositions comprising cryoprotective media that includes hydroxyethyl starch (HES) and glycerol or DMSO together
Directly injectable formulations which provide enhanced cryoprotection of cell products
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
1.0 Field of the Invention
The invention relates to compositions and methods for the cryopreservation of cellular vaccines. More specifically, the invention relates to the use of particular compositions comprising cryoprotective media that includes hydroxyethyl starch
Treatment of iodine deficiency diseases
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The present invention is concerned with the use of starch containing amylose as a complexant with iodine for preparing dry powder pharmaceutical formulations useful in the preparation of capsules or tablets. More particularly, the invention is concerned with the administration of molecular iodine
Composition for treating obesity comprising extract from white kidney beans, red kidney beans, and green tea leaves
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF INVENTION
This invention relates to the field of treating obesity, associated metabolic and physical aberrations such as altered plasma lipid profile and elevated blood pressure.
BACKGROUND
Obesity is rapidly becoming a major health problem in modern society. It is increasing in prevalence
Antitumor cystostatic and contrast agent
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF INVENTION
The invention relates to a composition for the treatment of tumors, its production and its use and, in particular, for the treatment of non-resectable primary and metastasized liver tumors.
BACKGROUND
In anti-tumor therapy of non-resectable liver tumors, the regional
Physiologically active peptides and a process for preparation thereof
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The following examples illustrate the present invention, but it is to be understood that they are given for the purpose of illustration and not limitation.
EXAMPLE 1
A medium (100 l) containing 6.0% soluble starch, 4.0% cotton seed meal, 0.2% (NH.sub.4).sub.2 SO.sub.4, 0.1% yeast extract, 0.2%
Database tanaman obat terlengkap yang didukung oleh sains
- Bekerja dalam 55 bahasa
- Pengobatan herbal didukung oleh sains
- Pengenalan herbal melalui gambar
- Peta GPS interaktif - beri tag herba di lokasi (segera hadir)
- Baca publikasi ilmiah yang terkait dengan pencarian Anda
- Cari tanaman obat berdasarkan efeknya
- Atur minat Anda dan ikuti perkembangan berita, uji klinis, dan paten
Ketikkan gejala atau penyakit dan baca tentang jamu yang mungkin membantu, ketik jamu dan lihat penyakit dan gejala yang digunakan untuk melawannya.
* Semua informasi didasarkan pada penelitian ilmiah yang dipublikasikan
